Featured news in The Life Sciences Report



ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Announces Q1/18 Results (5/11/2018)

view
 


Viveve Medical Inc. (VIVE:NASDAQ)
Announces Initiation of VIVEVE II Clinical Study (5/16/2018)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics' Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy (5/23/2018)

view
 


Athersys Inc. ()
INSYS Gets Negative FDA Recommendation for Pain Candidate (5/23/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Celgene Corporation To Contact The Firm (5/22/2018)

view
 


Athersys Inc. ()
Moving Average Crossover Alert: Athersys, Inc. (ATHX) (5/22/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Celgene Corporation (Nasdaq:CELG) To Contact The Firm (5/22/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
Today's Research Reports on Trending Tickers: Celgene and Foundation Medicine (5/22/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Celgene Corporation (CELG) and Lead Plaintiff Deadline: May 29, 2018 (5/22/2018)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Amarantus Retains Weild & Co. to Advise on JOBS Act Funding (5/22/2018)

view
 

Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
MANF Therapeutics Announces Publication in Society for Neuroscience eNeuro Journal of Human Ocular Distribution and Animal Photoreceptor Protection Data for MANF (5/21/2018)

view